David Horne

10.5k total citations · 4 hit papers
172 papers, 6.5k citations indexed

About

David Horne is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David Horne has authored 172 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 53 papers in Organic Chemistry and 33 papers in Oncology. Recurrent topics in David Horne's work include Marine Sponges and Natural Products (20 papers), Synthetic Organic Chemistry Methods (19 papers) and Cancer Mechanisms and Therapy (10 papers). David Horne is often cited by papers focused on Marine Sponges and Natural Products (20 papers), Synthetic Organic Chemistry Methods (19 papers) and Cancer Mechanisms and Therapy (10 papers). David Horne collaborates with scholars based in United States, India and France. David Horne's co-authors include Daniel R. Horne, Patricia A. Norberg, Kenichi Yakushijin, Claude R. Martin, Sharad S. Singhal, Sanjay Awasthi, Jyotsana Singhal, Fumiko Y. Miyake, Sangkil Nam and Shireen Chikara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

David Horne

162 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Privacy Paradox: Personal Information Disclosure Intentions versus Behaviors

2007 948 citations Daniel R. Horne, David Horne et al. profile →
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment

2017 410 citations David Horne, Sanjay Awasthi et al. profile →
The roles and implications of RNA m6A modification in cancer

2023 204 citations Xiaolan Deng, Ying Qing et al. Nature Reviews Clinical Oncology profile →
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells

2024 102 citations Jyoti Malhotra, Prakash Kulkarni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Horne United States	39	2.6k	1.5k	941	789	569	172	6.5k
Nobuyuki Takahashi Japan	57	5.0k 1.9×	207 0.1×	726 0.8×	365 0.5×	428 0.8×	312	12.2k
Eun‐Ju Lee South Korea	32	1.8k 0.7×	172 0.1×	660 0.7×	346 0.4×	490 0.9×	151	4.7k
Yung Hou Wong Hong Kong	50	4.6k 1.8×	143 0.1×	710 0.8×	792 1.0×	310 0.5×	271	9.5k
Jumin Lee United States	34	6.0k 2.3×	733 0.5×	2.9k 3.1×	404 0.5×	62 0.1×	81	12.2k
Peter Ulrich United States	38	1.8k 0.7×	931 0.6×	129 0.1×	248 0.3×	146 0.3×	163	7.3k
Luigi M. De Luca United States	42	4.1k 1.6×	168 0.1×	311 0.3×	565 0.7×	397 0.7×	172	7.7k
Yong‐Quan Li China	38	1.7k 0.7×	363 0.2×	537 0.6×	133 0.2×	71 0.1×	203	4.5k
Yoel Inbar Canada	26	1.8k 0.7×	274 0.2×	1.6k 1.7×	228 0.3×	62 0.1×	64	5.6k
Chien‐Huang Lin Taiwan	44	2.3k 0.9×	295 0.2×	161 0.2×	668 0.8×	718 1.3×	209	5.7k
David K. Perry United States	28	2.2k 0.8×	188 0.1×	617 0.7×	275 0.3×	111 0.2×	58	3.8k

Countries citing papers authored by David Horne

Since Specialization

Citations

This map shows the geographic impact of David Horne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Horne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Horne more than expected).

Fields of papers citing papers by David Horne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Horne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Horne. The network helps show where David Horne may publish in the future.

Co-authorship network of co-authors of David Horne

This figure shows the co-authorship network connecting the top 25 collaborators of David Horne. A scholar is included among the top collaborators of David Horne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Horne. David Horne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horne, David, et al.. (2026). Emerging trends and treatment strategies in ovarian cancer: A comprehensive review. Critical Reviews in Oncology/Hematology. 220. 105177–105177.

Wang, Yixing, Chen Wang, Jennifer Jossart, et al.. (2025). Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy. ACS Chemical Biology. 20(6). 1258–1272.

Horne, David, et al.. (2025). Molecular PET imaging: Unlocking the secrets of cancer metabolism. Biochemical Pharmacology. 242(Pt 3). 117202–117202.

Subbalakshmi, Ayalur Raghu, Atish Mohanty, Prakash Kulkarni, et al.. (2024). Emerging biomarkers and molecular targets for precision medicine in cervical cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(3). 189106–189106. 16 indexed citations

Sezgin, Erdinç, Yuelong Ma, David Horne, et al.. (2024). Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane. Translational Psychiatry. 14(1). 477–477. 4 indexed citations

Garg, Pankaj, et al.. (2024). Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. Journal of Clinical Medicine. 13(14). 4189–4189. 19 indexed citations

Deng, Xiaolan, Ying Qing, David Horne, Huilin Huang, & Jianjun Chen. (2023). The roles and implications of RNA m6A modification in cancer. Nature Reviews Clinical Oncology. 20(8). 507–526. 204 indexed citations breakdown →

Singhal, Sharad S., et al.. (2019). RLIP: An existential requirement for breast carcinogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 281–288. 10 indexed citations

Gu, Long, Robert Lingeman, Emily Sun, et al.. (2018). The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clinical Cancer Research. 24(23). 6053–6065. 33 indexed citations

10.

King, Jeremy D., Yuelong Ma, K.P. Bzymek, et al.. (2018). Template-Catalyzed, Disulfide Conjugation of Monoclonal Antibodies Using a Natural Amino Acid Tag. Bioconjugate Chemistry. 29(6). 2074–2081. 6 indexed citations

11.

Golfetto, Ottavia, Devin L. Wakefield, Kendra N. Avery, et al.. (2018). A Platform To Enhance Quantitative Single Molecule Localization Microscopy. Journal of the American Chemical Society. 140(40). 12785–12797. 25 indexed citations

12.

Bzymek, K.P., James W. Puckett, Cindy Zer, et al.. (2018). Mechanically interlocked functionalization of monoclonal antibodies. Nature Communications. 9(1). 1580–1580. 11 indexed citations

13.

Zhang, Xu Hannah, Sangkil Nam, Jun Wu, et al.. (2018). Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 138(11). 2377–2387. 20 indexed citations

14.

Bzymek, K.P., et al.. (2016). Cyclization strategies of meditopes: affinity and diffraction studies of meditope–Fab complexes. Acta Crystallographica Section F Structural Biology Communications. 72(6). 434–442. 7 indexed citations

15.

Zhou, Bingsen, Leila Su, Shuya Hu, et al.. (2013). A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance. Cancer Research. 73(21). 6484–6493. 65 indexed citations

16.

Sayre, Shay & David Horne. (2000). Trading Secrets For Savings: How Concerned Are Consumers About Club Cards As a Privacy Threat?. ACR North American Advances. 21 indexed citations

17.

Horne, David. (1999). ROAD SAFETY AUDITS: THE FEDERAL HIGHWAY ADMINISTRATION PERSPECTIVE. 3 indexed citations

18.

Horne, Daniel R. & David Horne. (1997). Privacy: a ParanoidS View. ACR North American Advances. 5 indexed citations

19.

Horne, Daniel R., Shay Sayre, & David Horne. (1996). Gifts: What Do You Buy the Person Who Has Everything? Nothing?. ACR North American Advances. 1 indexed citations

20.

Horne, David, et al.. (1987). Subject/Referent Positioning in Comparative Advertising: a Pilot Study. ACR North American Advances. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact